피부 발진 치료 시장 : 치료 유형별, 피부 발진 유형별, 유통 채널별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Skin Rash Treatment Market size was valued at USD 3,245.52 Million in 2023, expanding at a CAGR of 6.3% from 2024 to 2032.

The treatment of skin rashes encompasses a variety of approaches tailored to the underlying cause and severity of the condition. Typically, treatment options may involve the use of over-the-counter or prescription topical creams or ointments aimed at reducing inflammation and alleviating itching. In cases of persistent itching and discomfort, antihistamines may be prescribed, while severe instances may necessitate oral corticosteroids. It is crucial to identify and avoid triggers such as specific allergens or irritants to effectively manage chronic skin conditions. Moreover, maintaining proper skincare hygiene and utilizing gentle, non-irritating products can aid in preventing flare-ups and promoting healing.

Skin Rash Treatment Market Dynamics

Escalating prevalence of skin allergies and related conditions to propel market demand

The global prevalence of skin allergies and related conditions has exhibited a steady increase over recent decades. This rise is attributed to several factors, including escalating environmental pollution, shifts in lifestyle and dietary habits, and heightened exposure to chemicals. Urbanization has further compounded this trend, as city living exposes individuals to a multitude of allergens and irritants present in the environment on a daily basis. Research indicates that modern households now harbor numerous potential allergy triggers, found in commonly used products such as cleaning agents, air fresheners, fragranced personal care items, and synthetic furnishings. Concurrently, heightened awareness of various skin conditions has led to increased diagnoses, particularly in developing regions where advancements in medical infrastructure and diagnostic capabilities are underway. Demographic changes have also influenced prevalence rates, with both elderly and younger individuals exhibiting higher incidence rates of certain allergic skin conditions. Additionally, the pharmaceutical industry has played a significant role in raising public awareness about various skin issues through health campaigns, effectively contributing to greater recognition and understanding of these conditions among the general population.

Skin Rash Treatment Market Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2024-2032)

Based on Treatment Type segmentation, corticosteroids was predicted to show maximum market share in the year 2023

Based on Skin Rash Type segmentation, psoriasis was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Skin Rash Treatment Market Segmentation Analysis:

The Global Skin Rash Treatment Market is segmented on the basis of Treatment Type, Skin Rash Type, Distribution Channel, and Region.

The market is divided into five categories based on Treatment Type: Corticosteroids, Immunosuppressants, Antihistamines, Antifungals and Others. The corticosteroids segment is poised to maintain its dominant position in the market in 2023, primarily due to its efficacy in treating various types of skin rashes. Corticosteroids function by reducing inflammation and alleviating irritations and allergic reactions on the skin. They are particularly effective in providing temporary relief from symptoms associated with numerous inflammatory and autoimmune-based dermatological conditions such as eczema, psoriasis, and contact dermatitis. The escalating global incidence of these skin problems is fueling the demand for corticosteroid medications. According to studies released by Penn Medicine, an academic medical center, in March 2022, over 32 million Americans suffer from eczema, while more than 7.5 million Americans are afflicted with psoriasis. The recurrent nature of these conditions, coupled with the challenge of properly identifying triggers and preventing flare-ups, underscores the consistent necessity for effective treatment options, thus benefiting the corticosteroid segment. Furthermore, the proliferation of over-the-counter (OTC) corticosteroid formulations alongside prescription drugs has broadened their accessibility to a larger population, consequently bolstering the growth of this segment in the skin rash treatment market.

The market is divided into five categories based on Skin Rash Type: Contact Dermatitis, Atopic Dermatitis (Eczema), Psoriasis, Seborrheic Dermatitis and Others. The psoriasis segment is anticipated to lead the market share in 2023. Psoriasis manifests as patches of abnormal skin that are characterized by itchiness, scaliness, and inflammation. Flare-ups can occur frequently depending on triggers, causing discomfort and interfering with daily activities. Over time, psoriasis may elevate the risk of developing other serious health complications. With a substantial global patient pool affected by psoriasis, there remains a persistent demand for effective treatment and management options. This sustained demand is driving attention and new product development toward the psoriasis segment. Several biologics and other advanced therapies have been introduced in recent years, specifically targeting psoriasis and aiding patients in achieving better disease control. Moreover, increased awareness about psoriasis and available treatment options has encouraged more patients to seek medical intervention, thereby propelling the growth of the psoriasis segment in the skin rash treatment market.

Skin Rash Treatment Market Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Skin Rash Treatment Market Competitive Landscape:

In the competitive realm of skin rash treatment, companies frequently utilize strategic partnerships to bolster their market presence and provide comprehensive solutions. Collaborations between pharmaceutical firms and dermatologists or medical institutions can facilitate the development of innovative treatments and clinical trials. Partnerships with skincare brands or retail chains allow companies to broaden their distribution networks and reach a wider consumer base. Furthermore, alliances with research organizations or Treatment Type firms may spur advancements in diagnostics and personalized treatment approaches. By capitalizing on synergies through strategic partnerships, companies within the skin rash treatment market can fortify their competitive stance and effectively address the diverse needs of patients.

Recent Developments:

In May 2022, Dermavant Sciences, a biopharmaceutical company, announced the approval of VTAMA (tapinarof) cream, 1%, by the U.S. Food and Drug Administration (FDA). This cream, an aryl hydrocarbon receptor agonist, is indicated for the topical treatment of plaque psoriasis in adults. The approval marks VTAMA cream as the first and only FDA-approved steroid-free topical medication in its class, highlighting a significant advancement in the field.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SKIN RASH TREATMENT MARKET KEY PLAYERS DETAILED COMPETITIVE INSIGHT

AbbVie

Amgen

Bristol Myers Squibb

Galderma

Johnson & Johnson

LEO Pharma

Merck & Co. Inc.

Novartis AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Pvt. Ltd.

Teva Pharmaceutical Industries

Valeant Pharmaceuticals

Mylan N.V.

Perrigo Company plc

Eli Lilly and Company

Others

GLOBAL SKIN RASH TREATMENT MARKET, BY TREATMENT TYPE MARKET ANALYSIS, 2019 2032

• Corticosteroids
• Immunosuppressants
• Antihistamines
• Antifungals
• Others

GLOBAL SKIN RASH TREATMENT MARKET, BY SKIN RASH TYPE MARKET ANALYSIS, 2019 2032

• Contact Dermatitis
• Atopic Dermatitis (Eczema)
• Psoriasis
• Seborrheic Dermatitis
• Others

GLOBAL SKIN RASH TREATMENT MARKET, BY DISTRIBUTION CHANNEL MARKET ANALYSIS, 2019 2032

• Pharmacies
• Retail Stores
• Others GLOBAL SKIN RASH TREATMENT MARKET, BY REGION MARKET ANALYSIS, 2019 2032
• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.Skin Rash Treatment Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.Skin Rash Treatment Market Snippet by Treatment Type
  • 2.1.2.Skin Rash Treatment Market Snippet by Skin Rash Type
  • 2.1.3.Skin Rash Treatment Market Snippet by Distribution Channel
  • 2.1.4.Skin Rash Treatment Market Snippet by Country
  • 2.1.5.Skin Rash Treatment Market Snippet by Region
• 2.2.Competitive Insights

3.Skin Rash Treatment Key Market Trends

• 3.1.Skin Rash Treatment Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.Skin Rash Treatment Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.Skin Rash Treatment Market Opportunities
• 3.4.Skin Rash Treatment Market Future Trends

4.Skin Rash Treatment Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.Skin Rash Treatment Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.Skin Rash Treatment Market Landscape

• 6.1.Skin Rash Treatment Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.Skin Rash Treatment Market - By Treatment Type

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
  • 7.1.2.Corticosteroids
  • 7.1.3.Immunosuppressants
  • 7.1.4.Antihistamines
  • 7.1.5.Antifungals
  • 7.1.6.Others

8.Skin Rash Treatment Market - By Skin Rash Type

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By Skin Rash Type, 2023 & 2032 (%)
  • 8.1.2.Contact Dermatitis
  • 8.1.3.Atopic Dermatitis (Eczema)
  • 8.1.4.Psoriasis
  • 8.1.5.Seborrheic Dermatitis
  • 8.1.6.Others

9.Skin Rash Treatment Market - By Distribution Channel

• 9.1.Overview
  • 9.1.1.Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
  • 9.1.2.Pharmacies
  • 9.1.3.Retail Stores

10.Skin Rash Treatment Market- By Geography

• 10.1.Introduction
  • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2.North America
  • 10.2.1.Overview
  • 10.2.2.Skin Rash Treatment Key Manufacturers in North America
  • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4.North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  • 10.2.5.North America Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
  • 10.2.6.North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.2.7.U.S.
    • 10.2.7.1.Overview
    • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3.U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4.U.S. Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.2.7.5.U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.2.8.Canada
    • 10.2.8.1.Overview
    • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3.Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4.Canada Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.2.8.5.Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
• 10.3.Europe
  • 10.3.1.Overview
  • 10.3.2.Skin Rash Treatment Key Manufacturers in Europe
  • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4.Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  • 10.3.5.Europe Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
  • 10.3.6.Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.7.Germany
    • 10.3.7.1.Overview
    • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3.Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4.Germany Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.3.7.5.Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.8.Italy
    • 10.3.8.1.Overview
    • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3.Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4.Italy Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.3.8.5.Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.9.United Kingdom
    • 10.3.9.1.Overview
    • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3.United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4.United Kingdom Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.3.9.5.United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.10.France
    • 10.3.10.1.Overview
    • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3.France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4.France Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.3.10.5.France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.11.Russia
    • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2.Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3.Russia Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.3.11.4.Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.12.Netherlands
    • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2.Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3.Netherlands Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.3.12.4.Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.13.Sweden
    • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2.Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3.Sweden Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.3.13.4.Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.14.Poland
    • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2.Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3.Poland Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.3.14.4.Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3.15.Rest of Europe
    • 10.3.15.1.Overview
    • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
• 10.4.Asia Pacific (APAC)
  • 10.4.1.Overview
  • 10.4.2.Skin Rash Treatment Key Manufacturers in Asia Pacific
  • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4.Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  • 10.4.5.Asia Pacific Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
  • 10.4.6.Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.7.India
    • 10.4.7.1.Overview
    • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3.India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4.India Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.4.7.5.India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.8.China
    • 10.4.8.1.Overview
    • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3.China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4.China Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.4.8.5.China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.9.Japan
    • 10.4.9.1.Overview
    • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3.Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4.Japan Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.4.9.5.Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.10.South Korea
    • 10.4.10.1.Overview
    • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3.South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4.South Korea Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.4.10.5.South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.11.Australia
    • 10.4.11.1.Overview
    • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3.Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4.Australia Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.4.11.5.Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.12.Thailand
    • 10.4.12.1.Overview
    • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3.Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4.Thailand Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.4.12.5.Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.13.Indonesia
    • 10.4.13.1.Overview
    • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3.Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4.Indonesia Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.4.13.5.Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.14.Philippines
    • 10.4.14.1.Overview
    • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3.Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4.Philippines Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.4.14.5.Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4.15.Rest of APAC
    • 10.4.15.1.Overview
    • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3.Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4.Rest of APAC Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.4.15.5.Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
• 10.5.Latin America
  • 10.5.1.Overview
  • 10.5.2.Skin Rash Treatment Key Manufacturers in Latin America
  • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4.Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  • 10.5.5.Latin America Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
  • 10.5.6.Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.7.Brazil
    • 10.5.7.1.Overview
    • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3.Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4.Brazil Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.5.7.5.Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.8.Mexico
    • 10.5.8.1.Overview
    • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3.Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4.Mexico Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.5.8.5.Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.9.Argentina
    • 10.5.9.1.Overview
    • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3.Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4.Argentina Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.5.9.5.Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.10.Colombia
    • 10.5.10.1.Overview
    • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3.Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4.Colombia Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.5.10.5.Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5.11.Rest of LATAM
    • 10.5.11.1.Overview
    • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
• 10.6.Middle East and Africa
  • 10.6.1.Overview
  • 10.6.2.Skin Rash Treatment Key Manufacturers in Middle East and Africa
  • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4.Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
  • 10.6.5.Middle East and Africa Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
  • 10.6.6.Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.7.Saudi Arabia
    • 10.6.7.1.Overview
    • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.8.United Arab Emirates
    • 10.6.8.1.Overview
    • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.9.Israel
    • 10.6.9.1.Overview
    • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3.Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4.Israel Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.6.9.5.Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.10.Turkey
    • 10.6.10.1.Overview
    • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3.Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4.Turkey Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.6.10.5.Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.11.Algeria
    • 10.6.11.1.Overview
    • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3.Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4.Algeria Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.6.11.5.Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.12.Egypt
    • 10.6.12.1.Overview
    • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3.Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4.Egypt Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.6.12.5.Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6.13.Rest of MEA
    • 10.6.13.1.Overview
    • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3.Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4.Rest of MEA Market Size and Forecast, By Skin Rash Type, 2019 - 2032 (US$ Million)
    • 10.6.13.5.Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Skin Rash Treatment Industry

• 11.1.Competitive Dashboard
• 11.2.Company Profiles
  • 11.2.1.AbbVie
  • 11.2.2.Amgen
  • 11.2.3.Bristol Myers Squibb
  • 11.2.4.Galderma
  • 11.2.5.Johnson & Johnson
  • 11.2.6.LEO Pharma
  • 11.2.7.Merck & Co. Inc.
  • 11.2.8.Novartis AG
  • 11.2.9.Pfizer Inc.
  • 11.2.10.Sanofi
  • 11.2.11.Sun Pharmaceutical Industries Pvt. Ltd.
  • 11.2.12.Teva Pharmaceutical Industries
  • 11.2.13.Valeant Pharmaceuticals
  • 11.2.14.Mylan N.V.
  • 11.2.15.Perrigo Company plc
  • 11.2.16.Eli Lilly and Company
  • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

• 13.1.Research Methodology
• 13.2.References
• 13.3.Abbreviations
• 13.4.Disclaimer
• 13.5.Contact Us